A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

The advent of vaccinations came when a scientist, by the name of Edward Jenner, discovered that an individual exposed to a ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell ca ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...